Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2N7F

NMR solution structure of muO-conotoxin MfVIA

Summary for 2N7F
Entry DOI10.2210/pdb2n7f/pdb
NMR InformationBMRB: 25804
DescriptormuO-conotoxin MfVIA (1 entity in total)
Functional Keywordsmuo-conotoxin, diulfide-rich, toxin
Biological sourcesynthetic construct
Total number of polymer chains1
Total formula weight3656.41
Authors
Schroeder, C.I.,Mobli, M. (deposition date: 2015-09-09, release date: 2016-04-06, Last modification date: 2024-10-30)
Primary citationDeuis, J.R.,Dekan, Z.,Inserra, M.C.,Lee, T.H.,Aguilar, M.I.,Craik, D.J.,Lewis, R.J.,Alewood, P.F.,Mobli, M.,Schroeder, C.I.,Henriques, S.T.,Vetter, I.
Development of a mu O-Conotoxin Analogue with Improved Lipid Membrane Interactions and Potency for the Analgesic Sodium Channel NaV1.8.
J.Biol.Chem., 291:11829-11842, 2016
Cited by
PubMed Abstract: The μO-conotoxins MrVIA, MrVIB, and MfVIA inhibit the voltage-gated sodium channel NaV1.8, a well described target for the treatment of pain; however, little is known about the residues or structural elements that define this activity. In this study, we determined the three-dimensional structure of MfVIA, examined its membrane binding properties, performed alanine-scanning mutagenesis, and identified residues important for its activity at human NaV1.8. A second round of mutations resulted in (E5K,E8K)MfVIA, a double mutant with greater positive surface charge and greater affinity for lipid membranes compared with MfVIA. This analogue had increased potency at NaV1.8 and was analgesic in the mouse formalin assay.
PubMed: 27026701
DOI: 10.1074/jbc.M116.721662
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon